Mike Ellis, BSPharm

The cost of complex therapies is soaring, and the challenge is to deliver access to these medications in the most cost-effective and clinically appropriate site of service.

As part of its pharmacist-driven ConnectedCare Oral Oncology Program, Walgreens Specialty Pharmacy recently conducted a unique 3-month monitored-dispense pilot program, which reflects continued innovation, additional cost savings, and improved health care system communication.